EAGLE PHARMACEUTICALS, INC. Annual Depreciation in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2012 to 2022.
  • Eagle Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2023 was $110K, a 37.9% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Depreciation for 2022 was $646K, a 15.4% decline from 2021.
  • Eagle Pharmaceuticals, Inc. annual Depreciation for 2021 was $764K, a 12.4% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Depreciation for 2020 was $872K, a 10.3% decline from 2019.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $646K -$118K -15.4% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-23
2021 $764K -$108K -12.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $872K -$100K -10.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $972K -$183K -15.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 $1.16M +$223K +23.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-05
2017 $932K +$291K +45.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $641K +$529K +472% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $112K +$8K +7.69% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 $104K -$31K -23% Oct 1, 2013 Sep 30, 2014 10-K 2017-03-15
2013 $135K -$105K -43.8% Oct 1, 2012 Sep 30, 2013 10-K 2014-12-22
2012 $240K Oct 1, 2011 Sep 30, 2012 10-K 2014-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.